INSULIN, BIPHASIC injectable

Select language:
Enter
Permalink
Download
Comment
Return to top
On this page

     

    Prescription under medical supervision

     

    Therapeutic action

    • Pancreatic antidiabetic hormone: combination of short-acting + intermediate acting insulin 

    Indications

    • Diabetes

    Forms and strengths, route of administration

    • 1000 IU vial containing a combination of 30% short-acting insulin + 70% intermediate-acting insulin in suspension (100 IU/ml with a ratio of 30:70, 10 ml), for deep SC injection (abdomen, thigh, buttock or arm), administered with a syringe calibrated in insulin units for U-100 insulin (100 IU/ml).
      NEVER ADMINISTER BY IV INJECTION.

    Dosage

    • Child and adult: one to 2 injections daily 
    • Dosage must be individualised according to need. Adapt dose in the event of physical activity, change in diet or infection.

    Contra-indications, adverse effects, precautions

    Remarks

    • After removing vial from the refrigerator, leave to reach room temperature.
    • Shake the vial gently before use.
    • Also comes in biphasic human insulin 30/70 pens and biphasic analogue insulin 30/70 (aspart) and 25/75 (lispro) pens. 

    Storage

     
    –  Do not freeze.
    • Unopened vial: to be kept refrigerated (2 °C to 8 °C)
    • Opened vial: max. 4 weeks at below 25 °C and protected from light. Follow manufacturer’s instructions
    Path